Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Li

Showing results (101-110 of 139) with videos related to

Pageof 14
Sort By:
Translational Oncology|September 3, 2018
Chemotherapeutic Treatments Increase PD-L1 Expression in Esophageal Squamous Cell Carcinoma through EGFR/ERK ActivationHoi Yan Ng, Jian Li, Lihua Tao, et al.
Future Oncology (London, England)|March 9, 2023
Prolonging the life of people with metastatic breast cancer in routine clinical practice by adding palbociclib to an aromatase inhibitor from a real-world database analysis: a plain language summaryHope S Rugo, Adam Brufsky, Xianchen Liu, et al.
Circulation. Heart Failure|December 20, 2021
Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid CardiomyopathyPerry Elliott, Brian M Drachman, Stephen S Gottlieb, et al.
Frontiers in Oncology|April 28, 2022
Longitudinal Remote SBRT/SRS Training in Latin America: A Prospective Cohort StudyGustavo R Sarria, Ramsey Timmerman, Michael Hermansen, et al.
Targeted Oncology|July 10, 2023
Real-World Tumor Response of Palbociclib in Combination With an Aromatase Inhibitor as First-Line Therapy in Pre/Perimenopausal Women With Metastatic Breast CancerAngela DeMichele, Nicholas Robert, Connie Chen, et al.
Future Cardiology|January 30, 2023
Long-term survival in people with transthyretin amyloid cardiomyopathy who took tafamidis: A Plain Language SummaryPerry Elliott, Brian M Drachman, Stephen S Gottlieb, et al.
Cancers|October 13, 2021
Epigenetic Silencing of miR-33b Promotes Peritoneal Metastases of Ovarian Cancer by Modulating the TAK1/FASN/CPT1A/NF-κB AxisXueyu Wang, Mingo M H Yung, Rakesh Sharma, et al.
JCO Global Oncology|November 20, 2020
Impact of High-Dose-Rate Brachytherapy Training via Telehealth in Low- and Middle-Income CountriesJeremy B Hatcher, Oluwadamilola Oladeru, Betty Chang, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|September 4, 2020
Rationale for using a C-arm fluoroscope to deliver a kilovoltage radiotherapy treatment to COVID-19 patientsDante Roa, Harry Moyses, Stephanie Leon, et al.
Clinical Epigenetics|August 4, 2021
Correction to: Genome-wide DNA methylome analysis identifies methylation signatures associated with survival and drug resistance of ovarian cancersDavid W Chan, Wai-Yip Lam, Fushun Chen, et al.
Pageof 14

Showing results (101-110 of 139) with videos related to

Sort By:
Pageof 14
Translational Oncology|September 3, 2018
Chemotherapeutic Treatments Increase PD-L1 Expression in Esophageal Squamous Cell Carcinoma through EGFR/ERK ActivationHoi Yan Ng, Jian Li, Lihua Tao, et al.
Future Oncology (London, England)|March 9, 2023
Prolonging the life of people with metastatic breast cancer in routine clinical practice by adding palbociclib to an aromatase inhibitor from a real-world database analysis: a plain language summaryHope S Rugo, Adam Brufsky, Xianchen Liu, et al.
Circulation. Heart Failure|December 20, 2021
Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid CardiomyopathyPerry Elliott, Brian M Drachman, Stephen S Gottlieb, et al.
Frontiers in Oncology|April 28, 2022
Longitudinal Remote SBRT/SRS Training in Latin America: A Prospective Cohort StudyGustavo R Sarria, Ramsey Timmerman, Michael Hermansen, et al.
Targeted Oncology|July 10, 2023
Real-World Tumor Response of Palbociclib in Combination With an Aromatase Inhibitor as First-Line Therapy in Pre/Perimenopausal Women With Metastatic Breast CancerAngela DeMichele, Nicholas Robert, Connie Chen, et al.
Future Cardiology|January 30, 2023
Long-term survival in people with transthyretin amyloid cardiomyopathy who took tafamidis: A Plain Language SummaryPerry Elliott, Brian M Drachman, Stephen S Gottlieb, et al.
Cancers|October 13, 2021
Epigenetic Silencing of miR-33b Promotes Peritoneal Metastases of Ovarian Cancer by Modulating the TAK1/FASN/CPT1A/NF-κB AxisXueyu Wang, Mingo M H Yung, Rakesh Sharma, et al.
JCO Global Oncology|November 20, 2020
Impact of High-Dose-Rate Brachytherapy Training via Telehealth in Low- and Middle-Income CountriesJeremy B Hatcher, Oluwadamilola Oladeru, Betty Chang, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|September 4, 2020
Rationale for using a C-arm fluoroscope to deliver a kilovoltage radiotherapy treatment to COVID-19 patientsDante Roa, Harry Moyses, Stephanie Leon, et al.
Clinical Epigenetics|August 4, 2021
Correction to: Genome-wide DNA methylome analysis identifies methylation signatures associated with survival and drug resistance of ovarian cancersDavid W Chan, Wai-Yip Lam, Fushun Chen, et al.
Pageof 14